Durvalumab after chemoradiotherapy in stage III non-small cell lung cancer

J Thorac Dis. 2018 Apr;10(Suppl 9):S1032-S1036. doi: 10.21037/jtd.2018.04.61.

Authors

Pascale Tomasini^{1

2}, Laurent Greillier^{1

2}, Arnaud Boyer^{1

2}, Arnaud Jeanson^{1

2}, Fabrice Barlesi^{1

2}

Affiliations

¹ Aix Marseille University, Assistance Publique Hôpitaux de Marseille, Multidisciplinary Oncology & Therapeutic Innovations dpt, Marseille, France.
² Predictive Oncology Laboratory, Centre de Recherche en Cancérologie de Marseille, Inserm UMR1068, CNRS UMR7258, Aix-Marseille Université UM105, Marseille, France.

No abstract available

Publication types

Editorial
Comment